Thursday, November 22, 2007 2:42:20 AM
Pfizer Inc To Buy Coley Pharma For $8 A Share >PFE
Dow Jones Newswires - November 16, 2007 8:44 AM ET
Related Quotes
Symbol Last Chg
COLY Trade 7.75 +4.75
PFE Trade 23.40 +0.11
Real time quote.
DOW JONES NEWSWIRES
Pfizer Inc (PFE) has agreed to acquire Coley Pharmaceutical Group Inc. (COLY) for $8 a-share in cash.
The pharmaceutical company said the Coley deal has a $164 million enterprise value, and will form an important component of it's vaccine strategy.
The deal is expected to close in early 2008.
On Thursday, Pfizer shares closed down 32 cents, or 1.4%, to $23.39, while Coley shares closed down 7 cents, or 2.3%, to $3. Coley has about 26.5 million shares outstanding.
Dow Jones Newswires - November 16, 2007 8:44 AM ET
Related Quotes
Symbol Last Chg
COLY Trade 7.75 +4.75
PFE Trade 23.40 +0.11
Real time quote.
DOW JONES NEWSWIRES
Pfizer Inc (PFE) has agreed to acquire Coley Pharmaceutical Group Inc. (COLY) for $8 a-share in cash.
The pharmaceutical company said the Coley deal has a $164 million enterprise value, and will form an important component of it's vaccine strategy.
The deal is expected to close in early 2008.
On Thursday, Pfizer shares closed down 32 cents, or 1.4%, to $23.39, while Coley shares closed down 7 cents, or 2.3%, to $3. Coley has about 26.5 million shares outstanding.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
* Everything I've posted is in my unpaid opinion
as only as an inquisitve (potential) or actual shareholder of the particular stock message board I've posted on.
Recent MGRM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 01:59:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 01:58:09 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 01:57:01 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/07/2025 09:02:29 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/07/2025 09:00:25 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/07/2025 08:59:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2025 08:50:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2025 08:49:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2025 08:48:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 08:37:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2025 09:15:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 09:04:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 09:03:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 09:02:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/12/2025 07:16:11 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/05/2025 11:58:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2025 11:58:03 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/29/2025 07:50:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 07:49:06 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 08/28/2025 07:22:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2025 08:17:00 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 08/11/2025 09:28:17 PM
- Zimmer Biomet Announces Second Quarter 2025 Financial Results • PR Newswire (US) • 08/07/2025 10:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/31/2025 11:10:29 AM
